Tizanidine
- Product NDC
- 67296-1417
- 11-digit product format
- 672961417
- Labeler code
- 67296
- Product ID
- 67296-1417_b9bffbb6-7840-16ff-e053-2995a90a3d01
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc.
- Application
- ANDA076286
- Marketing category
- ANDA
- Marketing start
- 2002-07-03
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67296-1417-7 | Tizanidine | 15 in 1 BOTTLE | TABLET | 15 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67296-1417 | TIZANIDINE TABLET [REDPHARM DRUG, INC.] | 2 | Legacy NDC, 1 package rows | 20210127_b9bffbb6-783f-16ff-e053-2995a90a3d01.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67296-1417-7 | 67296141707 | 15 TABLET in 1 BOTTLE (67296-1417-7) | 15 tablet | 2021-01-01 | 0000-00-00 | No | No | Current |